Taro Pharmaceutical Industries Price Prediction

TARODelisted Stock  USD 42.97  0.00  0.00%   
As of today, The value of RSI of Taro Pharmaceutical's share price is at 57. This usually implies that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Taro Pharmaceutical, making its price go up or down.

Oversold Vs Overbought

57

 
Oversold
 
Overbought
The successful prediction of Taro Pharmaceutical's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Taro Pharmaceutical Industries, which may create opportunities for some arbitrage if properly timed.
Using Taro Pharmaceutical hype-based prediction, you can estimate the value of Taro Pharmaceutical Industries from the perspective of Taro Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Taro Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Taro because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Taro Pharmaceutical after-hype prediction price

    
  USD 42.97  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Intrinsic
Valuation
LowRealHigh
36.3236.3247.27
Details
Naive
Forecast
LowNextHigh
42.8542.8542.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
42.7442.9043.07
Details

Taro Pharmaceutical After-Hype Price Prediction Density Analysis

As far as predicting the price of Taro Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Taro Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Taro Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Taro Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Taro Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Taro Pharmaceutical's historical news coverage. Taro Pharmaceutical's after-hype downside and upside margins for the prediction period are 42.97 and 42.97, respectively. We have considered Taro Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
42.97
42.97
After-hype Price
42.97
Upside
Taro Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Taro Pharmaceutical is based on 3 months time horizon.

Taro Pharmaceutical Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Taro Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Taro Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Taro Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
8 Events / Month
10 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
42.97
42.97
0.00 
0.00  
Notes

Taro Pharmaceutical Hype Timeline

Taro Pharmaceutical is at this time traded for 42.97. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Taro is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Taro Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 42.97. About 78.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Taro Pharmaceutical last dividend was issued on the 10th of December 2018. The entity had 2:1 split on the 27th of July 2001. Given the investment horizon of 90 days the next projected press release will be in about 8 days.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Taro Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Taro Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Taro Pharmaceutical's future price movements. Getting to know how Taro Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Taro Pharmaceutical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
EGRXEagle Pharmaceuticals 0.00 0 per month 0.00 (0.19) 9.24 (8.24) 53.71 
ANIPANI Pharmaceuticals 0.21 10 per month 0.00 (0.08) 3.70 (3.75) 10.82 
PAHCPhibro Animal Health(0.59)12 per month 1.72  0.04  3.86 (2.45) 9.05 
DCPHDeciphera Pharmaceuticals LLC 0.00 0 per month 0.00 (0.15) 3.27 (3.25) 9.66 
PBHPrestige Brand Holdings(0.23)7 per month 1.03  0.09  1.90 (1.76) 5.58 
AMPHAmphastar P 2.13 7 per month 0.00 (0.08) 3.37 (3.61) 17.30 
PCRXPacira BioSciences, 0.12 9 per month 2.13  0.05  3.96 (3.67) 10.38 
COLLCollegium Pharmaceutical(0.86)8 per month 0.00 (0.17) 3.23 (4.47) 12.29 
ORGOOrganogenesis Holdings(0.1)7 per month 3.23  0.08  7.55 (5.54) 37.89 
LFCRLifecore Biomedical 0.47 9 per month 4.48  0.14  9.76 (5.78) 25.69 
RDHLRedhill Biopharma(0.36)10 per month 3.67  0.01  9.81 (6.57) 29.17 
EVOEvotec SE ADR 0.07 9 per month 5.42  0.07  9.82 (8.49) 33.99 
SUPNSupernus Pharmaceuticals 0.10 10 per month 2.01 (0.01) 2.77 (2.71) 12.87 
RDYDr Reddys Laboratories(0.06)7 per month 0.00 (0.27) 1.50 (2.20) 6.89 
PETQPetIQ Inc(0.08)9 per month 0.00  0.1  0.61 (1.32) 48.08 

Taro Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Taro price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Taro using various technical indicators. When you analyze Taro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Taro Pharmaceutical Predictive Indicators

The successful prediction of Taro Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Taro Pharmaceutical Industries, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Taro Pharmaceutical based on analysis of Taro Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Taro Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Taro Pharmaceutical's related companies.

Story Coverage note for Taro Pharmaceutical

The number of cover stories for Taro Pharmaceutical depends on current market conditions and Taro Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Taro Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Taro Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Taro Pharmaceutical Short Properties

Taro Pharmaceutical's future price predictability will typically decrease when Taro Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Taro Pharmaceutical Industries often depends not only on the future outlook of the potential Taro Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Taro Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding37.6 M
Cash And Short Term Investments879.4 M
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Consideration for investing in Taro Stock

If you are still planning to invest in Taro Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taro Pharmaceutical's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories